Global Autoimmune Disease Diagnostics Market Size, Status and Forecast 2021-2027

Publisher Name :
Date: 13-Jul-2021
No. of pages: 126
Inquire Before Buying

The diagnosis of autoimmune diseases depends on the identification of disease-associated clinical symptoms and is associated with the detection of autoantibodies. Clinicians conventionally classify autoimmune diseases as either systemic or organ-specific.

In terms of geography, the Americas led the global autoimmune disease diagnostics market and will continue to dominate the market in the coming years. The growing incidence of autoimmune disorders such as RA, SLE, and IBD will aid in the growth of this market. Also, the extensive R&D activities has allowed the launch of novel diagnostic products, which are expected to drive the adoption rates for autoimmune diagnostics in the Americas.

Market Analysis and Insights: Global Autoimmune Disease Diagnostics Market

The global Autoimmune Disease Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Autoimmune Disease Diagnostics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Autoimmune Disease Diagnostics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Autoimmune Disease Diagnostics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Autoimmune Disease Diagnostics market.

Global Autoimmune Disease Diagnostics Scope and Market Size

Autoimmune Disease Diagnostics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Autoimmune Disease Diagnostics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type

- Analyzers

- Assay Kits

Segment by Application

- Hospitals

- Research Laboratories

By Region

- North America

- - U.S.

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - Southeast Asia

- - India

- - Australia

- - Rest of Asia

- Latin America

- - Mexico

- - Brazil

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of MEA

By Company

- Abbott Laboratories

- Beckman Coulter

- Bio-Rad Laboratories

- EUROIMMUN

- Inova Diagnostics

- Roche Diagnostics

- Siemens Healthcare

- DiaSorin

- ERBA Diagnostics

- Euro Diagnostica

- Autoimmune Technologies

- Avant Diagnostics

- Exagen Diagnostics

- Gold Standard Diagnostics

- HOB Diagnostics

- HUMAN Diagnostics

- Immco Diagnostics

- ImmunArray

- Myriad Genetics

- Omega Diagnostics

- ORGENTEC Diagnostika

- Phadia

- Protagen

Global Autoimmune Disease Diagnostics Market Size, Status and Forecast 2021-2027

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Autoimmune Disease Diagnostics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Analyzers
1.2.3 Assay Kits
1.3 Market by Application
1.3.1 Global Autoimmune Disease Diagnostics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Research Laboratories
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Autoimmune Disease Diagnostics Market Perspective (2016-2027)
2.2 Autoimmune Disease Diagnostics Growth Trends by Regions
2.2.1 Autoimmune Disease Diagnostics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Autoimmune Disease Diagnostics Historic Market Share by Regions (2016-2021)
2.2.3 Autoimmune Disease Diagnostics Forecasted Market Size by Regions (2022-2027)
2.3 Autoimmune Disease Diagnostics Industry Dynamic
2.3.1 Autoimmune Disease Diagnostics Market Trends
2.3.2 Autoimmune Disease Diagnostics Market Drivers
2.3.3 Autoimmune Disease Diagnostics Market Challenges
2.3.4 Autoimmune Disease Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Autoimmune Disease Diagnostics Players by Revenue
3.1.1 Global Top Autoimmune Disease Diagnostics Players by Revenue (2016-2021)
3.1.2 Global Autoimmune Disease Diagnostics Revenue Market Share by Players (2016-2021)
3.2 Global Autoimmune Disease Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Autoimmune Disease Diagnostics Revenue
3.4 Global Autoimmune Disease Diagnostics Market Concentration Ratio
3.4.1 Global Autoimmune Disease Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Autoimmune Disease Diagnostics Revenue in 2020
3.5 Autoimmune Disease Diagnostics Key Players Head office and Area Served
3.6 Key Players Autoimmune Disease Diagnostics Product Solution and Service
3.7 Date of Enter into Autoimmune Disease Diagnostics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Autoimmune Disease Diagnostics Breakdown Data by Type
4.1 Global Autoimmune Disease Diagnostics Historic Market Size by Type (2016-2021)
4.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Type (2022-2027)
5 Autoimmune Disease Diagnostics Breakdown Data by Application
5.1 Global Autoimmune Disease Diagnostics Historic Market Size by Application (2016-2021)
5.2 Global Autoimmune Disease Diagnostics Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Autoimmune Disease Diagnostics Market Size (2016-2027)
6.2 North America Autoimmune Disease Diagnostics Market Size by Type
6.2.1 North America Autoimmune Disease Diagnostics Market Size by Type (2016-2021)
6.2.2 North America Autoimmune Disease Diagnostics Market Size by Type (2022-2027)
6.2.3 North America Autoimmune Disease Diagnostics Market Size by Type (2016-2027)
6.3 North America Autoimmune Disease Diagnostics Market Size by Application
6.3.1 North America Autoimmune Disease Diagnostics Market Size by Application (2016-2021)
6.3.2 North America Autoimmune Disease Diagnostics Market Size by Application (2022-2027)
6.3.3 North America Autoimmune Disease Diagnostics Market Size by Application (2016-2027)
6.4 North America Autoimmune Disease Diagnostics Market Size by Country
6.4.1 North America Autoimmune Disease Diagnostics Market Size by Country (2016-2021)
6.4.2 North America Autoimmune Disease Diagnostics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Autoimmune Disease Diagnostics Market Size (2016-2027)
7.2 Europe Autoimmune Disease Diagnostics Market Size by Type
7.2.1 Europe Autoimmune Disease Diagnostics Market Size by Type (2016-2021)
7.2.2 Europe Autoimmune Disease Diagnostics Market Size by Type (2022-2027)
7.2.3 Europe Autoimmune Disease Diagnostics Market Size by Type (2016-2027)
7.3 Europe Autoimmune Disease Diagnostics Market Size by Application
7.3.1 Europe Autoimmune Disease Diagnostics Market Size by Application (2016-2021)
7.3.2 Europe Autoimmune Disease Diagnostics Market Size by Application (2022-2027)
7.3.3 Europe Autoimmune Disease Diagnostics Market Size by Application (2016-2027)
7.4 Europe Autoimmune Disease Diagnostics Market Size by Country
7.4.1 Europe Autoimmune Disease Diagnostics Market Size by Country (2016-2021)
7.4.2 Europe Autoimmune Disease Diagnostics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Autoimmune Disease Diagnostics Market Size (2016-2027)
8.2 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Type
8.2.1 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Type (2016-2027)
8.3 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Application
8.3.1 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Application (2016-2027)
8.4 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region
8.4.1 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Autoimmune Disease Diagnostics Market Size (2016-2027)
9.2 Latin America Autoimmune Disease Diagnostics Market Size by Type
9.2.1 Latin America Autoimmune Disease Diagnostics Market Size by Type (2016-2021)
9.2.2 Latin America Autoimmune Disease Diagnostics Market Size by Type (2022-2027)
9.2.3 Latin America Autoimmune Disease Diagnostics Market Size by Type (2016-2027)
9.3 Latin America Autoimmune Disease Diagnostics Market Size by Application
9.3.1 Latin America Autoimmune Disease Diagnostics Market Size by Application (2016-2021)
9.3.2 Latin America Autoimmune Disease Diagnostics Market Size by Application (2022-2027)
9.3.3 Latin America Autoimmune Disease Diagnostics Market Size by Application (2016-2027)
9.4 Latin America Autoimmune Disease Diagnostics Market Size by Country
9.4.1 Latin America Autoimmune Disease Diagnostics Market Size by Country (2016-2021)
9.4.2 Latin America Autoimmune Disease Diagnostics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Autoimmune Disease Diagnostics Market Size (2016-2027)
10.2 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Type
10.2.1 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Type (2016-2027)
10.3 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Application
10.3.1 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Application (2016-2027)
10.4 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country
10.4.1 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Autoimmune Disease Diagnostics Introduction
11.1.4 Abbott Laboratories Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 Beckman Coulter
11.2.1 Beckman Coulter Company Details
11.2.2 Beckman Coulter Business Overview
11.2.3 Beckman Coulter Autoimmune Disease Diagnostics Introduction
11.2.4 Beckman Coulter Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.2.5 Beckman Coulter Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories Autoimmune Disease Diagnostics Introduction
11.3.4 Bio-Rad Laboratories Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 EUROIMMUN
11.4.1 EUROIMMUN Company Details
11.4.2 EUROIMMUN Business Overview
11.4.3 EUROIMMUN Autoimmune Disease Diagnostics Introduction
11.4.4 EUROIMMUN Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.4.5 EUROIMMUN Recent Development
11.5 Inova Diagnostics
11.5.1 Inova Diagnostics Company Details
11.5.2 Inova Diagnostics Business Overview
11.5.3 Inova Diagnostics Autoimmune Disease Diagnostics Introduction
11.5.4 Inova Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.5.5 Inova Diagnostics Recent Development
11.6 Roche Diagnostics
11.6.1 Roche Diagnostics Company Details
11.6.2 Roche Diagnostics Business Overview
11.6.3 Roche Diagnostics Autoimmune Disease Diagnostics Introduction
11.6.4 Roche Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.6.5 Roche Diagnostics Recent Development
11.7 Siemens Healthcare
11.7.1 Siemens Healthcare Company Details
11.7.2 Siemens Healthcare Business Overview
11.7.3 Siemens Healthcare Autoimmune Disease Diagnostics Introduction
11.7.4 Siemens Healthcare Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.7.5 Siemens Healthcare Recent Development
11.8 DiaSorin
11.8.1 DiaSorin Company Details
11.8.2 DiaSorin Business Overview
11.8.3 DiaSorin Autoimmune Disease Diagnostics Introduction
11.8.4 DiaSorin Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.8.5 DiaSorin Recent Development
11.9 ERBA Diagnostics
11.9.1 ERBA Diagnostics Company Details
11.9.2 ERBA Diagnostics Business Overview
11.9.3 ERBA Diagnostics Autoimmune Disease Diagnostics Introduction
11.9.4 ERBA Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.9.5 ERBA Diagnostics Recent Development
11.10 Euro Diagnostica
11.10.1 Euro Diagnostica Company Details
11.10.2 Euro Diagnostica Business Overview
11.10.3 Euro Diagnostica Autoimmune Disease Diagnostics Introduction
11.10.4 Euro Diagnostica Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.10.5 Euro Diagnostica Recent Development
11.11 Autoimmune Technologies
11.11.1 Autoimmune Technologies Company Details
11.11.2 Autoimmune Technologies Business Overview
11.11.3 Autoimmune Technologies Autoimmune Disease Diagnostics Introduction
11.11.4 Autoimmune Technologies Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.11.5 Autoimmune Technologies Recent Development
11.12 Avant Diagnostics
11.12.1 Avant Diagnostics Company Details
11.12.2 Avant Diagnostics Business Overview
11.12.3 Avant Diagnostics Autoimmune Disease Diagnostics Introduction
11.12.4 Avant Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.12.5 Avant Diagnostics Recent Development
11.13 Exagen Diagnostics
11.13.1 Exagen Diagnostics Company Details
11.13.2 Exagen Diagnostics Business Overview
11.13.3 Exagen Diagnostics Autoimmune Disease Diagnostics Introduction
11.13.4 Exagen Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.13.5 Exagen Diagnostics Recent Development
11.14 Gold Standard Diagnostics
11.14.1 Gold Standard Diagnostics Company Details
11.14.2 Gold Standard Diagnostics Business Overview
11.14.3 Gold Standard Diagnostics Autoimmune Disease Diagnostics Introduction
11.14.4 Gold Standard Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.14.5 Gold Standard Diagnostics Recent Development
11.15 HOB Diagnostics
11.15.1 HOB Diagnostics Company Details
11.15.2 HOB Diagnostics Business Overview
11.15.3 HOB Diagnostics Autoimmune Disease Diagnostics Introduction
11.15.4 HOB Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.15.5 HOB Diagnostics Recent Development
11.16 HUMAN Diagnostics
11.16.1 HUMAN Diagnostics Company Details
11.16.2 HUMAN Diagnostics Business Overview
11.16.3 HUMAN Diagnostics Autoimmune Disease Diagnostics Introduction
11.16.4 HUMAN Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.16.5 HUMAN Diagnostics Recent Development
11.17 Immco Diagnostics
11.17.1 Immco Diagnostics Company Details
11.17.2 Immco Diagnostics Business Overview
11.17.3 Immco Diagnostics Autoimmune Disease Diagnostics Introduction
11.17.4 Immco Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.17.5 Immco Diagnostics Recent Development
11.18 ImmunArray
11.18.1 ImmunArray Company Details
11.18.2 ImmunArray Business Overview
11.18.3 ImmunArray Autoimmune Disease Diagnostics Introduction
11.18.4 ImmunArray Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.18.5 ImmunArray Recent Development
11.18 Myriad Genetics
.1 Myriad Genetics Company Details
.2 Myriad Genetics Business Overview
.3 Myriad Genetics Autoimmune Disease Diagnostics Introduction
.4 Myriad Genetics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
.5 Myriad Genetics Recent Development
11.20 Omega Diagnostics
11.20.1 Omega Diagnostics Company Details
11.20.2 Omega Diagnostics Business Overview
11.20.3 Omega Diagnostics Autoimmune Disease Diagnostics Introduction
11.20.4 Omega Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.20.5 Omega Diagnostics Recent Development
11.21 ORGENTEC Diagnostika
11.21.1 ORGENTEC Diagnostika Company Details
11.21.2 ORGENTEC Diagnostika Business Overview
11.21.3 ORGENTEC Diagnostika Autoimmune Disease Diagnostics Introduction
11.21.4 ORGENTEC Diagnostika Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.21.5 ORGENTEC Diagnostika Recent Development
11.22 Phadia
11.22.1 Phadia Company Details
11.22.2 Phadia Business Overview
11.22.3 Phadia Autoimmune Disease Diagnostics Introduction
11.22.4 Phadia Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.22.5 Phadia Recent Development
11.23 Protagen
11.23.1 Protagen Company Details
11.23.2 Protagen Business Overview
11.23.3 Protagen Autoimmune Disease Diagnostics Introduction
11.23.4 Protagen Revenue in Autoimmune Disease Diagnostics Business (2016-2021)
11.23.5 Protagen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Autoimmune Disease Diagnostics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Analyzers
Table 3. Key Players of Assay Kits
Table 4. Global Autoimmune Disease Diagnostics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Autoimmune Disease Diagnostics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Autoimmune Disease Diagnostics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Autoimmune Disease Diagnostics Market Share by Regions (2016-2021)
Table 8. Global Autoimmune Disease Diagnostics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Autoimmune Disease Diagnostics Market Share by Regions (2022-2027)
Table 10. Autoimmune Disease Diagnostics Market Trends
Table 11. Autoimmune Disease Diagnostics Market Drivers
Table 12. Autoimmune Disease Diagnostics Market Challenges
Table 13. Autoimmune Disease Diagnostics Market Restraints
Table 14. Global Autoimmune Disease Diagnostics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Autoimmune Disease Diagnostics Market Share by Players (2016-2021)
Table 16. Global Top Autoimmune Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Diagnostics as of 2020)
Table 17. Ranking of Global Top Autoimmune Disease Diagnostics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Autoimmune Disease Diagnostics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Autoimmune Disease Diagnostics Product Solution and Service
Table 21. Date of Enter into Autoimmune Disease Diagnostics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Autoimmune Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2016-2021)
Table 25. Global Autoimmune Disease Diagnostics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Autoimmune Disease Diagnostics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Autoimmune Disease Diagnostics Revenue Market Share by Application (2016-2021)
Table 29. Global Autoimmune Disease Diagnostics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Autoimmune Disease Diagnostics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Autoimmune Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Autoimmune Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Autoimmune Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Autoimmune Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Autoimmune Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Autoimmune Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Autoimmune Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Autoimmune Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Autoimmune Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Autoimmune Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Autoimmune Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Autoimmune Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Autoimmune Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Autoimmune Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Autoimmune Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Autoimmune Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Autoimmune Disease Diagnostics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Autoimmune Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Autoimmune Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Autoimmune Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Autoimmune Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Autoimmune Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Autoimmune Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Autoimmune Disease Diagnostics Market Size by Country (2022-2027) & (US$ Million)
Table 61. Abbott Laboratories Company Details
Table 62. Abbott Laboratories Business Overview
Table 63. Abbott Laboratories Autoimmune Disease Diagnostics Product
Table 64. Abbott Laboratories Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 65. Abbott Laboratories Recent Development
Table 66. Beckman Coulter Company Details
Table 67. Beckman Coulter Business Overview
Table 68. Beckman Coulter Autoimmune Disease Diagnostics Product
Table 69. Beckman Coulter Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 70. Beckman Coulter Recent Development
Table 71. Bio-Rad Laboratories Company Details
Table 72. Bio-Rad Laboratories Business Overview
Table 73. Bio-Rad Laboratories Autoimmune Disease Diagnostics Product
Table 74. Bio-Rad Laboratories Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 75. Bio-Rad Laboratories Recent Development
Table 76. EUROIMMUN Company Details
Table 77. EUROIMMUN Business Overview
Table 78. EUROIMMUN Autoimmune Disease Diagnostics Product
Table 79. EUROIMMUN Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 80. EUROIMMUN Recent Development
Table 81. Inova Diagnostics Company Details
Table 82. Inova Diagnostics Business Overview
Table 83. Inova Diagnostics Autoimmune Disease Diagnostics Product
Table 84. Inova Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 85. Inova Diagnostics Recent Development
Table 86. Roche Diagnostics Company Details
Table 87. Roche Diagnostics Business Overview
Table 88. Roche Diagnostics Autoimmune Disease Diagnostics Product
Table 89. Roche Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 90. Roche Diagnostics Recent Development
Table 91. Siemens Healthcare Company Details
Table 92. Siemens Healthcare Business Overview
Table 93. Siemens Healthcare Autoimmune Disease Diagnostics Product
Table 94. Siemens Healthcare Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 95. Siemens Healthcare Recent Development
Table 96. DiaSorin Company Details
Table 97. DiaSorin Business Overview
Table 98. DiaSorin Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 99. DiaSorin Recent Development
Table 100. ERBA Diagnostics Company Details
Table 101. ERBA Diagnostics Business Overview
Table 102. ERBA Diagnostics Autoimmune Disease Diagnostics Product
Table 103. ERBA Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 104. ERBA Diagnostics Recent Development
Table 105. Euro Diagnostica Company Details
Table 106. Euro Diagnostica Business Overview
Table 107. Euro Diagnostica Autoimmune Disease Diagnostics Product
Table 108. Euro Diagnostica Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 109. Euro Diagnostica Recent Development
Table 110. Autoimmune Technologies Company Details
Table 111. Autoimmune Technologies Business Overview
Table 112. Autoimmune Technologies Autoimmune Disease Diagnostics Product
Table 113. Autoimmune Technologies Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 114. Autoimmune Technologies Recent Development
Table 115. Avant Diagnostics Company Details
Table 116. Avant Diagnostics Business Overview
Table 117. Avant Diagnostics Autoimmune Disease Diagnostics Product
Table 118. Avant Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 119. Avant Diagnostics Recent Development
Table 120. Exagen Diagnostics Company Details
Table 121. Exagen Diagnostics Business Overview
Table 122. Exagen Diagnostics Autoimmune Disease Diagnostics Product
Table 123. Exagen Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 124. Exagen Diagnostics Recent Development
Table 125. Gold Standard Diagnostics Company Details
Table 126. Gold Standard Diagnostics Business Overview
Table 127. Gold Standard Diagnostics Autoimmune Disease Diagnostics Product
Table 128. Gold Standard Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 129. Gold Standard Diagnostics Recent Development
Table 130. HOB Diagnostics Company Details
Table 131. HOB Diagnostics Business Overview
Table 132. HOB Diagnostics Autoimmune Disease Diagnostics Product
Table 133. HOB Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 134. HOB Diagnostics Recent Development
Table 135. HUMAN Diagnostics Company Details
Table 136. HUMAN Diagnostics Business Overview
Table 137. HUMAN Diagnostics Autoimmune Disease Diagnostics Product
Table 138. HUMAN Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 139. HUMAN Diagnostics Recent Development
Table 140. Immco Diagnostics Company Details
Table 141. Immco Diagnostics Business Overview
Table 142. Immco Diagnostics Autoimmune Disease Diagnostics Product
Table 143. Immco Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 144. Immco Diagnostics Recent Development
Table 145. ImmunArray Company Details
Table 146. ImmunArray Business Overview
Table 147. ImmunArray Autoimmune Disease Diagnostics Product
Table 148. ImmunArray Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 149. ImmunArray Recent Development
Table 150. Myriad Genetics Company Details
Table 151. Myriad Genetics Business Overview
Table 152. Myriad Genetics Autoimmune Disease Diagnostics Product
Table 153. Myriad Genetics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 154. Myriad Genetics Recent Development
Table 155. Omega Diagnostics Company Details
Table 156. Omega Diagnostics Business Overview
Table 157. Omega Diagnostics Autoimmune Disease Diagnostics Product
Table 158. Omega Diagnostics Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 159. Omega Diagnostics Recent Development
Table 160. ORGENTEC Diagnostika Company Details
Table 161. ORGENTEC Diagnostika Business Overview
Table 162. ORGENTEC Diagnostika Autoimmune Disease Diagnostics Product
Table 163. ORGENTEC Diagnostika Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 164. ORGENTEC Diagnostika Recent Development
Table 165. Phadia Company Details
Table 166. Phadia Business Overview
Table 167. Phadia Autoimmune Disease Diagnostics Product
Table 168. Phadia Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 169. Phadia Recent Development
Table 170. Protagen Company Details
Table 171. Protagen Business Overview
Table 172. Protagen Autoimmune Disease Diagnostics Product
Table 173. Protagen Revenue in Autoimmune Disease Diagnostics Business (2016-2021) & (US$ Million)
Table 174. Protagen Recent Development
Table 175. Research Programs/Design for This Report
Table 176. Key Data Information from Secondary Sources
Table 177. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Autoimmune Disease Diagnostics Market Share by Type: 2020 VS 2027
Figure 2. Analyzers Features
Figure 3. Assay Kits Features
Figure 4. Global Autoimmune Disease Diagnostics Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Research Laboratories Case Studies
Figure 7. Autoimmune Disease Diagnostics Report Years Considered
Figure 8. Global Autoimmune Disease Diagnostics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 9. Global Autoimmune Disease Diagnostics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 10. Global Autoimmune Disease Diagnostics Market Share by Regions: 2020 VS 2027
Figure 11. Global Autoimmune Disease Diagnostics Market Share by Regions (2022-2027)
Figure 12. Global Autoimmune Disease Diagnostics Market Share by Players in 2020
Figure 13. Global Top Autoimmune Disease Diagnostics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Autoimmune Disease Diagnostics as of 2020
Figure 14. The Top 10 and 5 Players Market Share by Autoimmune Disease Diagnostics Revenue in 2020
Figure 15. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2016-2021)
Figure 16. Global Autoimmune Disease Diagnostics Revenue Market Share by Type (2022-2027)
Figure 17. North America Autoimmune Disease Diagnostics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 18. North America Autoimmune Disease Diagnostics Market Share by Type (2016-2027)
Figure 19. North America Autoimmune Disease Diagnostics Market Share by Application (2016-2027)
Figure 20. North America Autoimmune Disease Diagnostics Market Share by Country (2016-2027)
Figure 21. United States Autoimmune Disease Diagn
  • In Vitro Fertilization /IVF Market by Product (Micromanipulators, Incubators, Cabinets, Imaging System, Laser System, Reagents & Accessories), Type (Conventional IVF, IVF with ICSI), End User (Fertility Clinics, Hospitals, Cryobanks) - Global Forecast to 2026
    Published: 24-Nov-2021        Price: US 4950 Onwards        Pages: 241
     “The global in vitro fertilization market size is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1 % during the forecast period”  The global in vitro fertilization market is projected to reach USD 987 million by 2026 from USD 638 million in 2021, at a CAGR of 9.1% from 2021 to 2026. The key factors fueling the growth of this market include an in......
  • China Preimplantation Genetic Diagnosis Market Report & Forecast 2021-2027
    Published: 18-Nov-2021        Price: US 3400 Onwards        Pages: 90
    China Preimplantation Genetic Diagnosis Market, By Type, 2016-2021, 2022-2027 ($ Millions) China Preimplantation Genetic Diagnosis Market Segment Percentages, By Type, 2020 (%) - Genetic Diagnosis - Genetic Screening China Preimplantation Genetic Diagnosis Market, By Application, 2016-2021, 2022-2027 ($ Millions) China Preimplantation Genetic Diagnosis Market Segment Percentages, By Application, 2020 (%) - Fertility Clinics - Research......
  • China In Vitro Diagnostics (IVD) Market Report & Forecast 2021-2027
    Published: 12-Nov-2021        Price: US 3400 Onwards        Pages: 90
    China In Vitro Diagnostics(IVD) Market, By Type, 2016-2021, 2022-2027 ($ Millions) China In Vitro Diagnostics(IVD) Market Segment Percentages, By Type, 2020 (%) - Reagents - Instruments - Software and Services China In Vitro Diagnostics(IVD) Market, By Application, 2016-2021, 2022-2027 ($ Millions) China In Vitro Diagnostics(IVD) Market Segment Percentages, By Application, 2020 (%) - Standalone Laboratory - Hospitals - Academ......
  • Global In Vitro Diagnostics Partnering Terms and Agreements 2014-2021
    Published: 01-Nov-2021        Price: US 3495 Onwards        Pages: 400
    The Global In Vitro Diagnostics Partnering Terms and Agreements 2014-2021 report provides a detailed understanding and analysis of how and why companies enter in vitro diagnostics partnering deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. This report provides details of the latest In Vitro Diagnostics agreements announced in the life sciences since 2014. The report takes the reader through a comprehensive......
  • Global and United States Anti-nuclear Antibody (ANA) Testing Market Size, Status and Forecast 2021-2027
    Published: 29-Oct-2021        Price: US 3900 Onwards        Pages: 108
    Global Anti-nuclear Antibody (ANA) Testing Scope and Market Size Anti-nuclear Antibody (ANA) Testing market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Anti-nuclear Antibody (ANA) Testing market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the peri......
  • Global Pharmaceutical Testing Services Market 2021 by Company, Regions, Type and Application, Forecast to 2026
    Published: 28-Oct-2021        Price: US 3480 Onwards        Pages: 115
    The Pharmaceutical Testing Services market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations. According to ou......
  • China IVD Products Market Report & Forecast 2021-2027
    Published: 21-Oct-2021        Price: US 3400 Onwards        Pages: 111
    China IVD Products Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units) China IVD Products Market Segment Percentages, By Type, 2020 (%) - Reagents - Kits - Instruments China IVD Products Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units) China IVD Products Market Segment Percentages, By Application, 2020 (%) - Diabetes - Infectious Diseases - Oncology - Cardiology - Drug Testing......
  • China In-Vitro Diagnostics Products Market Report & Forecast 2021-2027
    Published: 21-Oct-2021        Price: US 3400 Onwards        Pages: 93
    China In-Vitro Diagnostics Products Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (Units) China In-Vitro Diagnostics Products Market Segment Percentages, By Type, 2020 (%) - In-Vitro Diagnostics Instruments - In-Vitro Diagnostics Reagents - In-Vitro Diagnostics Software China In-Vitro Diagnostics Products Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (Units) China In-Vitro Diagnostics Products Market Segment Percentages, By A......
  • 2021 Rapid Lateral Flow Diagnostics Market: Africa, Asia, Latin America, Middle East--Dengue Fever, H. Pylori, HBs Ag, Syphilis, Toxoplasmosis, Typhoid Fever
    Published: 20-Oct-2021        Price: US 4500 Onwards        Pages: 0
    This unique 8-country report from LeadingMarketResearch.com provides granular data not available from any other source.  Lateral Flow Tests Analyzed in the Report -Dengue Fever -Helicobacter Pylori -HBs Ag -Syphilis -Toxoplasmosis -Typhoid Fever Country Analyses Brazil India Indonesia Iraq Peru Saudi Arabia South Africa Vietnam Sales and Market Share Analysis......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs